Status:
UNKNOWN
Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD
Lead Sponsor:
The First Affiliated Hospital of Guangdong Pharmaceutical University
Conditions:
Nonalcoholic Fatty Liver Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a randomised clinical trial which aims to evaluate the efficacy of Compound Zhenzhu Tiaozhi capsules in the treatment of NAFLD and analyze the relationship between improvement in NAFLD paramet...
Detailed Description
This is a randomised clinical trial which aims to evaluate the efficacy of Compound Zhenzhu Tiaozhi capsules in the treatment of NAFLD and analyze the relationship between improvement in NAFLD paramet...
Eligibility Criteria
Inclusion
- clinical diagnosis of simple steatosis or NASH 18 to 75 years old serum alanine transaminase (ALT)≤2 times the upper limit of normal
Exclusion
- other chronic liver diseases serious complications in other organs malignant tumors
Key Trial Info
Start Date :
December 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT03375580
Start Date
December 31 2017
End Date
December 31 2019
Last Update
December 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, Guangdong, China, 510080